top of page
MEMO logo_purple_PNG-transparent.png

Transforming Epilepsy Research and Drug Discovery 

Modular Platform for Epilepsy Modelling (MEMO) offers best-in class solution for seizure activity detection and epilepsy modelling  in vitro

arvo 160622 JR 54.jpg

Advanced, Humanized and Cell-based

Modular Platform for Epilepsy Modelling in vitro

 MEMO platform is devoted to solve following challenges

arvo 160622 JR 40.jpg

Finding novel approaches to discover truly innovative anti-seizure medicatons

arvo 160622 JR 42.jpg

Accomplish CNS safety testing for seizure liability early enough during drug discovery

arvo 160622 JR 49.jpg

Advancing tools to reveal  disease mechanisms of epilepsies

MEMO platform

MEMO whole device (1)_edited.png
Gas supply chamber
Medium Reservoirs
Microfluidic device
Microelec-trode array

Microfluidic device 

arvo 160622 JR 32_edited.jpg

Three-compartment microfluidic device enables formation of axonally connected brain-like circuitry of neuronal networks 

arvo 160622 JR 32_edited.jpg

Microelectrode Array

Customized microelectrode array

 enables the neuronal network and seizure-like activity measurements

coeboc arvo 160322 JR 100_edited.jpg

Data Analysis

MEA data is analyzed by

our own smart algorithms

About Us 

MEMO is an advanced platform technology innovated in a project owned by Tampere University, Finland. MEMO platform bases on the strong and impactful neuroscientific and microfabrication technology backgrounds of NeuroGroup (led by Adj. Prof Susanna Narkilahti) and Micro- and Nanosystems Research group (led by Prof Pasi Kallio). 


MEMO project is a Research to Business project, aiming to the commercialization of research results and is funded by Business Finland.

arvo 160622 JR 27.jpg

MEMO project team

Our team has over 15 years of experience in combining neuroscience and engineering technologies.  We have excellent hands-on expertise of human pluripotent stem cells, neuronal cultures, microfluidics, microelectrode arrays and data analysis. MEMO project has a comprehensive steering group from the fields of business and engineering technologies as well as epilepsy and drug R&D research.

Susanna Narkilahti

Adj. Prof. Neuroscience Specialist, stem cells, in vitro models 

arvo 160622 JR 18_edited.jpg

Satu Jäntti

MSc, Business Champion, Cell Technology Scientist

arvo 160622 JR 15_edited.jpg

Jouni Sirviö

PhD, Senior Expert, Neuroscience, Drug development

arvo 160622 JR 19_edited.jpg

Hanna Mäkelä

Laboratory Specialist

arvo 160622 JR 11_edited.jpg

Pasi Kallio

Prof. Engineering Specialist, Nano- and microfluidic systems

arvo 160622 JR 23_edited.jpg

Lassi Sukki

MSc, Microfluidic and Microfabrication Specialist 


Timo Salpavaara

PhD,  Sensors and Electronics Specialist, Microfabrication


Anna Vallius


arvo 160622 JR 10_edited_edited.jpg

Clinical advisor

Jukka Peltola, 

Prof. of Neurology, 

Chief Physician

Want to know more?  Interested in collaboration? 

Project Leader

Susanna Narkilahti


Business Champion

Satu Jäntti


Kauppi Campus

Tampere University 

Arvo Ylpön Katu 34

33520 Tampere, Finland

bottom of page